Tivumecirnon (FLX475) is an orally active, selective CCR4 antagonist. Tivumecirnon blocks the binding of CCR4 to its ligands, CCL17 and CCL22, thereby reducing Treg infiltration into the tumor microenvironment. Tivumecirnon has antitumor activity[1][2][3][4].
Molecular Weight:
543.41
Purity:
99.48
CAS Number:
[2174938-78-2]
Formula:
C24H27Cl2F3N6O
Target:
CCR
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted